Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1982-7-8
pubmed:abstractText
1 The metabolism of antipyrine to its three main oxidative metabolites, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norphenazone was investigated in vivo and in vitro in separate groups of subjects with normal hepatic function and in the same group of patients with suspected liver disease. 2 The rank order for the rate of formation of the three metabolites of antipyrine was similar in vivo and in vitro. 3 There was no significant correlation between the rates of formation of any pair of antipyrine metabolites either in vivo or in vitro. 4 Despite this there was a significant correlation between the in vivo and in vitro rates for formation of each of the three metabolites in the same group of patients. 5 It is concluded that determination of rates of formation of antipyrine metabolites from their excretion in urine provides an indication of the activity of the enzymes involved in their formation.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-111889, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-119355, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-399809, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-4146319, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-433309, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-4356419, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-4418208, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-4593769, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-4611464, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-461498, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-4813341, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-487696, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-522906, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-533575, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-5389794, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-5690279, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-6105054, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-6766729, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-732536, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-7362740, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-7448333, http://linkedlifedata.com/resource/pubmed/commentcorrection/7340879-849678
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0306-5251
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
771-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't